4531 Stock Overview
Researches, develops, manufactures, and markets fine chemical products in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Yuki Gosei Kogyo Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥308.00 |
| 52 Week High | JP¥359.00 |
| 52 Week Low | JP¥275.00 |
| Beta | 0.64 |
| 1 Month Change | 0.98% |
| 3 Month Change | -5.81% |
| 1 Year Change | 5.48% |
| 3 Year Change | 2.33% |
| 5 Year Change | 36.89% |
| Change since IPO | -56.00% |
Recent News & Updates
Shareholder Returns
| 4531 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 0.3% | -2.0% | -1.2% |
| 1Y | 5.5% | 20.9% | 23.9% |
Return vs Industry: 4531 underperformed the JP Chemicals industry which returned 20.9% over the past year.
Return vs Market: 4531 underperformed the JP Market which returned 23.9% over the past year.
Price Volatility
| 4531 volatility | |
|---|---|
| 4531 Average Weekly Movement | 3.9% |
| Chemicals Industry Average Movement | 3.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 7.8% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4531 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4531's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 295 | Seiichiro Matsumoto | www.yuki-gosei.co.jp |
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients.
Yuki Gosei Kogyo Co., Ltd. Fundamentals Summary
| 4531 fundamental statistics | |
|---|---|
| Market cap | JP¥6.72b |
| Earnings (TTM) | JP¥776.00m |
| Revenue (TTM) | JP¥12.93b |
8.7x
P/E Ratio0.5x
P/S RatioIs 4531 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4531 income statement (TTM) | |
|---|---|
| Revenue | JP¥12.93b |
| Cost of Revenue | JP¥9.67b |
| Gross Profit | JP¥3.26b |
| Other Expenses | JP¥2.48b |
| Earnings | JP¥776.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 35.55 |
| Gross Margin | 25.21% |
| Net Profit Margin | 6.00% |
| Debt/Equity Ratio | 52.4% |
How did 4531 perform over the long term?
See historical performance and comparison